Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro-Reference-Cited by-同舟云学术

Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro

Published:2012-08 Issue:1 Volume:47 Page:44-55
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Gschwind Hans-Peter,Glaenzel Ulrike,Waldmeier Felix,Wirz Bernard,Sabia Helene D.,Picard Franck,Markus Weiss H.,Choi Leslie,Swart Pieter Jacob,Vasudevan Ajithkumar,Azria Moïse

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. The Calcitonins. Physiology and Pharmacology;Azria,1989

2. 25 Years of salmon calcitonin: from synthesis to therapeutic use;Azria;Calcif. Tissue Int.,1995

3. Fatty acid metabolism;Berg,2001

4. Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers;Buclin;J. Bone Miner. Res.,2002

5. Prevention and treatment of osteoporosis;Chapuy;Aging (Milano),1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico, in situ, in vitro, and in vivo predictive methods for modeling formulation performance;From Current to Future Trends in Pharmaceutical Technology;2024

2. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023

3. Formulation strategies to improve the efficacy of intestinal permeation enhancers,;Advanced Drug Delivery Reviews;2021-10

4. Advances in oral peptide therapeutics;Nature Reviews Drug Discovery;2019-12-17

5. Preclinical models for colonic absorption, application to controlled release formulation development;European Journal of Pharmaceutics and Biopharmaceutics;2018-09